Field trial of a vaccine against new world cutaneous leishmaniasis in an at-risk child population: How long does protection last?

Journal of Infectious Diseases

Volumn 187, Issue 12, 2003, Pages 1959-1961

  Armijos, Rodrigo X ^a,b   Weigel, M Margaret ^a   Romero, Luciano ^b   Garcia, Vinicio ^b   Salazar, Jorge ^b  

^a UNIVERSITY OF TEXAS AT EL PASO   (United States)

^b UNIVERSIDAD CENTRAL DEL ECUADOR   (Ecuador)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; BCG VACCINE; LEISHMANIA VACCINE;

ARTICLE; CALCULATION; CHILD; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ECUADOR; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PARASITE INCIDENCE; POPULATION RESEARCH; PRIORITY JOURNAL; PROMASTIGOTE; RANDOMIZED CONTROLLED TRIAL; SKIN LEISHMANIASIS; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BCG VACCINE; CHILD; CHILD, PRESCHOOL; ECUADOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LEISHMANIA; LEISHMANIASIS; MALE; PROTOZOAN VACCINES; RISK FACTORS; TIME FACTORS;

EID: 0037562848     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/375399     Document Type: Article

References (6)

1. Armijos RX, Weigel MM, Aviles H, Maldonado R, Racines J. Field trial of a vaccine against New World cutaneous leishmaniasis in an at-risk child population: safety, immunogenicity, and efficacy during the first 12 months of follow-up. J Infect Dis 1998; 177:1352-7.
2. Armijos RX, Weigel MM, Izurieta R, et al. The epidemiology of cutaneous leishmaniasis in an endemic area of subtropical Ecuador. Trop Med Int Health 1997; 2:140-52.
3. Armijos RX, Chico ME, Cruz ME, et al. Human cutaneous leishmaniasis in Ecuador: identification of parasites by enzyme electrophoresis. Am J Trop Med Hyg 1990; 45(5):424-8.
4. Dean AG, Dean JA, Coulombier D, et al. Epi Info, version 6: a word-processing, database, and statistics program for public health on IBM-compatible microcomputers. Centers for Disease Control and Prevention, Atlanta, Georgia 1995.
5. Mayrink W, da Costa CA, Magalhaes PA, et al. A field trial of a vaccine against American dermal leishmaniasis. Trans R Soc Trop Med Hyg 1979; 73:385-7.
6. Armijos RX, Weigel MM, Hidalgo A, Cevallos W, Correa J. Safety, immunogenicity, and efficacy of an autoclaved Leishmania amazonesis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis. Vaccine (in press).